Question

Fact Pattern 46-1
Quality Pharmaceuticals, Inc. (QPI), makes the prescription drug Reflux. Substitute Drugs Company (SDC) develops a generic version. SDC agrees not to market the generic in exchange for $40 million per year from QPI until a dispute between them over the patent for the drug is resolved.
Refer to Fact Pattern 46-1. The agreement between QPI and SDC is
a. a horizontal restraint.
b. a legitimate joint venture.
c. a reasonable price-fixing agreement.
d. a vertical restraint.

Answer

This answer is hidden. It contains 1 characters.